Gabriele Alessandrini

Istituti di Ricovero e Cura a Carattere Scientifico, National Cancer Institute

Papers

Total Citations

H-Index

About

Dr. Gabriele Alessandrini is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer, particularly robotic-assisted procedures for non-small cell lung cancer (NSCLC). His major contributions lie in evaluating the perioperative benefits of robotic surgery, including pain management and recovery outcomes. In his pilot study on multimodal evaluation of locoregional anaesthesia efficacy after robotic pulmonary lobectomy, Dr. Alessandrini demonstrated how refined anesthetic protocols can significantly reduce postoperative pain, offering patients a faster, more comfortable recovery. His comparative work on robotic versus open thoracotomy after neoadjuvant treatment for locally advanced NSCLC is equally impactful, showing that robotic approaches can improve short-term outcomes without compromising oncologic efficacy. With his most-cited paper already garnering 3 citations and his 2025 study receiving early attention, Dr. Alessandrini is shaping the future of thoracic oncology by proving that robotic surgery can extend beyond early-stage disease. His research bridges surgical innovation and patient-centered care, making him a key voice in the evolution of lung cancer treatment.